- News Home
6 March 2014 1:04 pm ,
Vol. 343 ,
Magdalena Koziol, a former postdoc at Yale University, was the victim of scientific sabotage. Now, she is suing the...
Antiretroviral drugs can protect people from becoming infected by HIV. But so-called pre-exposure prophylaxis, or PrEP...
Two studies show that eating a diet low in protein and high in carbohydrates is linked to a longer, healthier life, and...
Considered an icon of conservation science, researchers at World Wildlife Fund (WWF) headquarters in Washington, D.C.,...
The new atlas, which shows the distribution of important trace metals and other substances, is the first product of...
Early in April, the first of a fleet of environmental monitoring satellites will lift off from Europe's spaceport in...
Since 2000, U.S. government health research agencies have spent almost $1 billion on an effort to churn out thousands...
- 6 March 2014 1:04 pm , Vol. 343 , #6175
- About Us
A Sweet Way to Grow Blood Vessels
1 July 2012 1:20 pm
Imagine a world where if your heart or kidneys failed, you wouldn't have to endure an agonizing, possibly futile wait for a donor whose organ your body might reject. Instead, a doctor would simply take cells from your own body and use them to "grow" you a new organ. One of the main obstacles to such tissue engineering has been producing the network of tiny blood vessels that keep newly growing natural tissue alive. But now a new technique, based on material used by the candy industry, may have brought a solution closer.
The technology of cell culture has advanced drastically in the past few decades to the point where it's now possible to culture skin in a laboratory and transplant it onto a patient. Engineered bladders are also now in clinical trials. But both skin and bladders are thin membranes which, if transplanted into the body, can be supplied with blood from pre-existing vessels. Growing a replacement version of a thick chunk of tissue like a heart or a kidney requires engineering a network of connected channels into the tissue to act as blood vessels. Without them, the cells on the inside would be starved of oxygen and nutrients and would quickly die.
Various research groups have tried to solve this problem. One avenue has involved casting molds of blood vessels, and then culturing tissue around them. The molds must then be dissolved so that the organ can function properly. Getting rid of the molds is hard to do, however, without killing the living tissue. If the mold were made of rubber, for example, a researcher would have to use a toxic solvent to dissolve it.
The new study solves that problem by turning to a material used by the food industry. As they report online today in Nature Materials, scientists at the University of Pennsylvania and colleagues have developed a water-soluble carbohydrate glass based on a decoration used on cakes and lollipops. The material can be cast into a variety of shapes, is completely nontoxic, and, when it has done its job, will dissolve naturally in the moist environment of the cells, leaving behind spaces that can carry blood to cells.
To test the quality of the "blood vessels" produced, the researchers cultured a chunk of tissue made from rat liver cells using their technique. The cells at the center of the tissue stayed alive and functioning after the scaffold had dissolved, showing that the vessels were successfully carrying blood to the cells, says team member and bioengineer Christopher Chen.
The study is "a useful step in this effort to develop fully functional tissues with blood vessels," says chemical engineer Abraham Stroock of Cornell University, who also works on engineering blood vessels in tissue using different techniques.
Both Stroock and Chen insist, however, that there is still much work to be done before scientists can even contemplate growing new, implantable organs. For example, real organs are not simply chunks of tissue interlaced with blood vessels, but internally structured machines comprising various kinds of tissue all working together to do a job. Replicating this complexity will be a huge challenge, Chen says.
Stroock hopes that more short-term goals might be achievable, however. He says that it may soon be possible to take healthy liver cells from a patient whose liver is failing and use them to make tissue that would be stored in the laboratory. While such tissue would not be suitable for implantation, it could, says Stroock, make a kind of personalized, living dialysis machine for the patient, as well as being a step toward the goal of producing replacement organs.